Title
Category
Credits
Event date
Cost
- Suicide
- 1.00 AMA PRA Category 1 Credit™
$0.00
Suicide was declared a public health crisis by the U.S. Surgeon General in 1999. However, suicide rates continued to climb over the past two decades by a staggering 35% (1999-2018). Fortunately, we have seen decreases in the national suicide rates from 2018-2020. The pandemic’s impact on mental health is a major focus of public health concern and while distress and mental health suffering have increased, the suicide rate in the US actually decreased by 3% from 2019 to 2020.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
$15.00
Vector-borne diseases are spread by arthropods such as ticks, mosquitoes, or fleas. In the U.S., ticks are the number one vector responsible for transmission to humans. These tickborne diseases are challenging to diagnose as they often have non-specific symptoms. Healthcare staff must be knowledgeable about how to prevent, recognize, and treat tickborne illnesses.REL-ACU-0-TBD
- Drug Diversion
- 1.25 AMA PRA Category 1 Credit™
$20.00
Many state medical licensing boards have already or will soon require healthcare professionals to complete mandated continuing education that addresses prescribing controlled substances. Misuse and abuse of prescribed controlled substances can lead to serious consequences, including addiction and overdose. Understanding the signs of abuse of medications such as opioids, sedatives, and stimulants is important to safe prescribing of controlled substances. This course will teach healthcare providers about substance use disorder and how to identify signs and symptoms of misuse and abuse.
- Post-traumatic Stress Disorder (PTSD)
- Pharmacology
- 15.00 AMA PRA Category 1 Credit™
- 15.00 ANCC
- 15.00 ASWB
$105.00
Primary care practitioners treat many civilians and veterans of all ages who exhibit symptoms of PTSD, but many lack the necessary knowledge to identify PTSD and perform differential diagnosis. Also necessary is an understanding of the circumstances that can lead to the development of PTSD and appreciation of the emotional and physical needs of that result from different traumas and different time intervals from the exposure. This course will provide the necessary knowledge and skills to appropriately identify and treat patients with acute stress disorder and PTSD.
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
- 2.00 ASWB
$15.00
The effects of deployment to military combat on the individual and the family system are wide-reaching and can be severe. Military personnel may confront numerous potentially traumatizing experiences, including military-specific events and those experienced by civilians. Research suggests the most common traumatic events experienced during active duty are witnessing someone badly injured or killed or unexpectedly seeing a dead body.
- Prescribing: Opioid(s)
- Pain Management: Acute
- Pain Management: Chronic
- 3.00 AMA PRA Category 1 Credit™
$75.00
- State Mandated Training
- 0.50 Participation
$0.00
This video covers an introduction and description of the Utah Controlled Substance Database, Utah CSD act, law and regulations, CSD account creation, patient and prescriber dashboards, proxy information and medication disposal.This training fulfills 0.5 hours towards the Controlled Substance Training CE requirement of Utah Code §58-37-6.5.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ASWB
$0.00
An Online Training by CALM Produced by Intermountain Health for Colorado, Idaho, Kansas, Montana, Nevada, Utah, and Wyoming.
- Cognitive Impairment
- 0.58 AANP Contact Hours
- 0.50 AMA PRA Category 1 Credit™
$0.00
In the context of a patient case presentation, expert faculty will highlight the stages of Alzheimer disease (AD) and the vital importance of early detection of mild cognitive impairment (MCI). They will discuss screening for MCI and current guidelines and standards of care for establishing a diagnosis of AD. The faculty will also examine the effects of increasingly more accessible neuroimaging and fluid markers on the diagnosis of AD, especially with the recent FDA approvals of anti-amyloid therapies.
- Infectious Diseases
- 5.00 AMA PRA Category 1 Credit™
- 5.00 ANCC
- 5.00 ASWB
$35.00
Since the discovery of HIV, scientists have made major inroads in understanding modes of transmission, infectivity, and pathogenicity. Knowledge about the characteristics and behavior of this human retrovirus and its complex mechanisms of immunopathogenesis has helped to develop targeted therapeutic interventions and vaccine strategies. Sophisticated techniques have been and are being developed to diagnose infection, to monitor immune decline, to monitor response to therapy and disease progression, and to accurately detect and diagnose opportunistic diseases.